Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Tesei

Showing results (21-30 of 98) with videos related to

Pageof 10
Sort By:
Molecular Imaging and Biology|October 19, 2022
Pro-inflammatory RNA:DNA Hybrids Are p53 Independently Boosted by Hyperbaric Oxygen: a Subcellular Distribution Analysis by Automated Quantitative ImagingIlaria De Santis, Michele Zanoni, Sara Pignatta, et al.
Journal of Visualized Experiments : Jove|December 30, 2017
Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-downChiara Arienti, Sara Pignatta, Michele Zanoni, et al.
International Journal of Oncology|September 6, 2007
Comparative evaluation of C1311 cytotoxic activity and interference with cell cycle progression in a panel of human solid tumour and leukaemia cell linesCinzia De Marco, Nadia Zaffaroni, Elizabeth Comijn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2002
In Vitro schedule-dependent interactions between the multitargeted antifolate LY231514 and gemcitabine in human colon adenocarcinoma cell linesAnna Tesei, Luca Ricotti, Franca De Paola, et al.
Lung Cancer (Amsterdam, Netherlands)|January 11, 2005
Innovative sequence of docetaxel-gemcitabine based on preclinical data in the treatment of advanced non small cell lung cancer: a phase I studyToni Ibrahim, Wainer Zoli, Giovanni Luca Frassineti, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Nonsteroidal androgen receptor ligands: versatile syntheses and biological dataGreta Varchi, Andrea Guerrini, Anna Tesei, et al.
The Prostate|October 1, 2009
Docetaxel-ST1481 sequence exerts a potent cytotoxic activity on hormone-resistant prostate cancer cells by reducing drug resistance-related gene expressionFrancesco Fabbri, Giovanni Brigliadori, Silvia Carloni, et al.
Oncotarget|July 13, 2014
Anti-tumor activity of fenretinide complexed with human serum albumin in lung cancer xenograft mouse modelSandra Durante, Isabella Orienti, Gabriella Teti, et al.
Nitric Oxide : Biology and Chemistry|May 13, 2008
NCX 4040, an NO-donating acetylsalicylic acid derivative: efficacy and mechanisms of action in cancer cellsAnna Tesei, Wainer Zoli, Francesco Fabbri, et al.
Expert Opinion on Therapeutic Patents|January 5, 2017
Are sigma modulators an effective opportunity for cancer treatment? A patent overview (1996-2016)Simona Collina, Emanuele Bignardi, Marta Rui, et al.
Pageof 10

Showing results (21-30 of 98) with videos related to

Sort By:
Pageof 10
Molecular Imaging and Biology|October 19, 2022
Pro-inflammatory RNA:DNA Hybrids Are p53 Independently Boosted by Hyperbaric Oxygen: a Subcellular Distribution Analysis by Automated Quantitative ImagingIlaria De Santis, Michele Zanoni, Sara Pignatta, et al.
Journal of Visualized Experiments : Jove|December 30, 2017
Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-downChiara Arienti, Sara Pignatta, Michele Zanoni, et al.
International Journal of Oncology|September 6, 2007
Comparative evaluation of C1311 cytotoxic activity and interference with cell cycle progression in a panel of human solid tumour and leukaemia cell linesCinzia De Marco, Nadia Zaffaroni, Elizabeth Comijn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2002
In Vitro schedule-dependent interactions between the multitargeted antifolate LY231514 and gemcitabine in human colon adenocarcinoma cell linesAnna Tesei, Luca Ricotti, Franca De Paola, et al.
Lung Cancer (Amsterdam, Netherlands)|January 11, 2005
Innovative sequence of docetaxel-gemcitabine based on preclinical data in the treatment of advanced non small cell lung cancer: a phase I studyToni Ibrahim, Wainer Zoli, Giovanni Luca Frassineti, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Nonsteroidal androgen receptor ligands: versatile syntheses and biological dataGreta Varchi, Andrea Guerrini, Anna Tesei, et al.
The Prostate|October 1, 2009
Docetaxel-ST1481 sequence exerts a potent cytotoxic activity on hormone-resistant prostate cancer cells by reducing drug resistance-related gene expressionFrancesco Fabbri, Giovanni Brigliadori, Silvia Carloni, et al.
Oncotarget|July 13, 2014
Anti-tumor activity of fenretinide complexed with human serum albumin in lung cancer xenograft mouse modelSandra Durante, Isabella Orienti, Gabriella Teti, et al.
Nitric Oxide : Biology and Chemistry|May 13, 2008
NCX 4040, an NO-donating acetylsalicylic acid derivative: efficacy and mechanisms of action in cancer cellsAnna Tesei, Wainer Zoli, Francesco Fabbri, et al.
Expert Opinion on Therapeutic Patents|January 5, 2017
Are sigma modulators an effective opportunity for cancer treatment? A patent overview (1996-2016)Simona Collina, Emanuele Bignardi, Marta Rui, et al.
Pageof 10